Sarepta Therapeutics
SRPT
#5089
Rank
$1.83 B
Marketcap
$17.40
Share price
-0.97%
Change (1 day)
-9.94%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Number of shares outstanding for Sarepta Therapeutics (SRPT)

Number of shares outstanding as of October 2026 : 105,431,000

According to Sarepta Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 105,431,000. At the end of 2026 the company had 105,431,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Sarepta Therapeutics from 2012 to 2026

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20260.10 B0.61%
20250.10 B8.84%
202496.28 M8.32%
202388.88 M1.44%
202287.62 M9.7%
202179.88 M1.76%
202078.5 M5.83%
201974.17 M8.05%
201868.65 M6.81%
201764.27 M17.68%
201654.61 M21.69%
201544.88 M8.66%
201441.3 M9.86%
201337.59 M64.72%
201222.82 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Gilead Sciences
GILD
1,243,000,000 1,078.97%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
83,006,808-21.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
164,574,000 56.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
133,606,000 26.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
217,352,000 106.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
254,481,000 141.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
137,895,000 30.79%๐Ÿ‡บ๐Ÿ‡ธ USA